anxiety approved benzodiazepines depression drugs fright gibson health literature medical medication medicine medina pharmaceuticals psicofarmaci-del-cazzo public relaxant sedative speaking spookcountry stage

My tags:

From Wikipedia, the free encyclopedia

Benzodiazepines
Benzodiazepine
List of benzodiazepines
Benzodiazepine overdose
Benzodiazepine dependence
Benzodiazepine withdrawal syndrome
Long term effects of benzodiazepines

The benzodiazepines (pronounced /ˌbɛnzəʊdaɪˈæzəˌpiːn/, often abbreviated to "benzos") are a class of psychoactive drugs with varying hypnotic, sedative, anxiolytic (antianxiety), anticonvulsant, muscle relaxant, and amnesic properties, which are mediated by slowing down the central nervous system.^[1] Benzodiazepines are useful in treating anxiety, insomnia, agitation, seizures, and muscle spasms, as well as alcohol withdrawal. They can also be used before certain medical procedures such as endoscopies or dental work where tension and anxiety are present, and prior to some unpleasant medical procedures in order to induce sedation and amnesia^[2] for the procedure. Another use is to counteract anxiety-related symptoms upon initial use of SSRIs and other antidepressants, or as an adjunctive treatment. Recreational stimulant users often use benzodiazepines as a means of "coming down." Benzodiazepines are also used to treat the panic that can be caused by hallucinogen intoxication.^[3][4]

Benzodiazepines can cause a physical dependence and a benzodiazepine addiction to develop and upon cessation of long term use a benzodiazepine withdrawal syndrome can occur.^[5]

Contents 1 History 2 Pharmacology 2.1 Mechanism of action 2.2 Duration of action 3 Benzodiazepines and their therapeutic uses 3.1 Anticonvulsants 3.2 Anxiolytics 3.3 Insomnia 3.4 Premedication before procedures 3.5 Intensive care 3.6 Alcohol dependence 3.7 Muscular disorders 3.8 Acute mania 3.9 Veterinary practice 4 Contraindications, interactions and side effects 4.1 Contraindications 4.2 Interactions 4.3 Side-effects 4.3.1 Paradoxical reactions 5 Physical dependence and withdrawal 5.1 Withdrawal management 6 Pregnancy 7 Elderly 8 Overdose 9 Benzodiazepine drug misuse 9.1 Drug misuse 9.2 Drug related crime 10 Drug regulation and enforcement 10.1 Europe 10.2 Oceania 10.3 North America 10.4 East and Southeast Asia 11 Legal status 12 See also 13 References 14 External links

[edit] History

The first benzodiazepine, chlordiazepoxide (Librium) was discovered serendipitously in 1954 by the Austrian scientist Leo Sternbach (1908–2005), working for the pharmaceutical company Hoffmann–La Roche. Chlordiazepoxide was synthesised by accident while trying to synthesise a chemical dye. The chemical class synthesised was initially believed to be heptoxdiazines but on further investigation Leo Sternbach soon discovered the new compound was in fact quinazolone-3-oxides. Leo Sternbach had synthesised 40 derivatives of the quinazolone-3-oxides and tested 39 of them with disappointing results. Leo Sternbach discontinued his work on the remaining compound Ro-5-0690, but he "rediscovered" it in 1957 when an assistant was cleaning up the laboratory. Although initially discouraged by his employer, Sternbach conducted further research that revealed the compound was a very effective tranquilizer. Tests revealed that the compound had hypnotic, anxiolytic, anticonvulsant, and muscle relaxant effects. Three years later chlordiazepoxide was marketed as a therapeutic benzodiazepine medication under the brand name Librium. Following chlordiazepoxide, in 1963 diazepam hit the market under the brand name Valium, followed by oxazepam (Serax) and nitrazepam (Mogadon) in 1965, clorazepate (Tranxene) in 1968, lorazepam (Ativan) in 1973, bromazepam (Lexotan) in 1974, clobazam (Frisium) in 1975, and flunitrazepam (Rohypnol) in 1978.^[6]

Dr. Carl F. Essig of the Addiction Research Center of the National Institute of Mental Health spoke at a symposium on drug abuse at an annual meeting of the American Association for the Advancement of Science, in December 1963. He named meprobamate, glutethimide, ethinamate, ethchlorvynol, methyprylon, and chlordiazepoxide as drugs whose usefulness can hardly be questioned. However, Essig labeled these newer products as drugs of addiction, like barbiturates, whose habit-forming qualities were more widely known. He mentioned a 90-day study of chlordiazepoxide, which concluded that the automobile accident rate among 68 users was 10 times higher than normal. Participants' daily dosage ranged from 5 to 100 milligrams.^[7]

A related class of drugs that also work on the benzodiazepine receptors, the nonbenzodiazepines, has recently been introduced.^[8] Nonbenzodiazepines are molecularly distinct from benzodiazepines and have similar risks and benefits to those of benzodiazepines. There have been suggestions that they may have a better side effect profile with less dependence potential. However, this is controversial and disputed by bodies such as the National Institute for Clinical Excellence.^[9][10]

[edit] Pharmacology

[edit] Mechanism of action

Benzodiazepines produce a range of effects from depressing the central nervous system via modulating the GABA_A receptor, the most prevalent inhibitory receptor within the brain. The subset of GABA_A receptors that also bind benzodiazepines are referred to as benzodiazepine receptors (BzR). The GABA_A receptor is composed of five subunits, most commonly two α's, two β's, and one γ (α₂β₂γ). For each subunit, multiple subtypes exist (α_1-6, β_1-3, and γ_1-3). GABA_A receptors that are made up of different combinations of subunit subtypes have different properties, different distributions within the brain, and different activities relative to pharmacological and clinical effects.

Benzodiazepines bind at the interface of the α and γ subunits on the GABA_A receptor. Benzodiazepine binding also requires that alpha subunits contain a histidine amino acid residue, (i.e., α₁, α₂, α₃ and α₅ containing GABA_A receptors). For this reason, benzodiazepines show no affinity for GABA_A receptors containing α₄ and α₆ subunits, which contain an arginine instead of a histidine residue.^[11] Other sites on the GABA_A receptor also bind neurosteroids, barbiturates and certain anesthetics.^[12] Individual types of subunits are expressed more densely in certain brain regions and thus modulation of certain subunits produces certain therapeutic as well as adverse effects of benzodiazepines. The α₄ and α₆ are expressed in very low numbers in the brain.^[13]

The binding of GABA to the GABA binding site increases the binding affinity of benzodiazepines for their binding site.^[14] Once bound to the BzR, the benzodiazepine ligand locks the BzR into a conformation in which it has a much higher affinity for the GABA neurotransmitter than otherwise. This increases the frequency of opening of the associated chloride ion channel and hyperpolarizes the membrane of the associated neuron. This potentiates the inhibitory effect of the available GABA, leading to sedatory and anxiolytic effects. As mentioned above, different benzodiazepines can have different affinities for BzRs made up of different collection of subunits. For instance, benzodiazepines with high activity at the α₁ (temazepam, triazolam, nitrazepam, etc) are associated with sedation, whereas those with higher affinity for GABA_A receptors containing α₂ and/or α₃ subunits (diazepam, clonazepam, bromazepam, etc) have good anti-anxiety activity.^[15] Benzodiazepines also bind to glial cell membranes.^[16]

Some compounds lie somewhere between being full agonists and neutral antagonists, and are termed either partial agonists or partial antagonists. There has been interest in partial agonists for the BzR, with evidence that complete tolerance may not occur with chronic use, with partial agonists demonstrating continued anxiolytic properties with reduced sedation, dependence, and withdrawal problems.^[17]

The anticonvulsant properties of benzodiazepines may be in part or entirely due to binding to voltage-dependent sodium channels rather than benzodiazepine receptors. Sustained repetitive firing seems to be limited by benzodiazepines effect of slowing recovery of sodium channels from inactivation.^[18]

Benzodiazepine receptors also appear in a number of non nervous-system tissues and are mainly of the peripheral benzodiazepine receptor (PBRs) type. These peripheral benzodiazepine receptors are not coupled (or "attached") to GABA_A receptors. These are found in various tissues such as heart, liver, adrenal, and testis, as well as hemopoietic and lymphatic cells.^[19] In lymphatic tissues, they modulate apoptosis of thymocytes via reduction of mitochondrial transmembrane potential.^[20] PBRs have many other actions on immune cells including modulation of oxidative bursts by neutrophils and macrophages, and inhibition of macrophage secretion of cytokines inhibition of the proliferation of lymphoid cells and secretion of cytokines by macrophages.^[21]

[edit] Duration of action

Benzodiazepines are commonly divided into three groups by their half-lives: Short-acting compounds have a half-life of less than 12 hours, and have few residual effects if taken before bedtime, but rebound insomnia may occur and they might cause wake-time anxiety. Intermediate-acting compounds have a half-life of 12–24 hours, may have residual effects in the first half of the day. Rebound insomnia however is more common upon discontinuation of short-acting benzodiazepines. Daytime withdrawal symptoms are also a problem with prolonged usage of short-acting benzodiazepines, including daytime anxiety. Long-acting compounds have a half-life greater than 24 hours.^[22][23]

[edit] Benzodiazepines and their therapeutic uses

The core chemical structure of "classical" benzodiazepine drugs is a fusion between the benzene and diazepine ring systems. Many of these drugs contain the 5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one substructure (see figure to the above right). Benzodiazepines are molecularly similar to several groups of drugs, some of which share similar pharmacological properties, including the quinazolinones, hydantoines, succinimides, oxazolidinediones, barbiturates and glutarimides.^[24][25] Most benzodiazepines are administered orally; however, administration can also occur intravenously, intramuscularly, sublingually or as a suppository. Benzodiazepines have a number of therapeutic uses, are well-tolerated, and are very safe and effective drugs in the short term for a wide range of conditions.

[edit] Anticonvulsants

Main anticonvulsant benzodiazepines
clobazam clonazepam clorazepate diazepam lorazepam midazolam

Benzodiazepines are potent anticonvulsants and have life-saving properties in the acute management of status epilepticus. The most commonly-used benzodiazepines for seizure control are lorazepam and diazepam. A meta-analysis of 11 clinical trials concluded that lorazepam was superior to diazepam in treating persistent seizures.^[26] Although diazepam is much longer-acting than lorazepam, lorazepam has a more prolonged anticonvulsant effect. This is because diazepam is very lipid-soluble and highly protein-bound, and has a very large distribution of unbound drug, resulting in diazepam's having only a 20– to 30-minute duration of action against status epilepticus. Lorazepam, however, has a much smaller volume of distribution of unbound drug, which results in a more prolonged duration of action against status epilepticus. Lorazepam can therefore be considered superior to diazepam, at least in the initial stages of treatment of status epilepticus.^[27] Long term prophylactic use of benzodiazepines for seizure disorders is limited due to a high risk of tolerance to the anticonvulsant effects of benzodiazepines.^[28][29][30]

[edit] Anxiolytics

Main anxiolytic benzodiazepines
alprazolam bromazepam chlordiazepoxide clonazepam clorazepate diazepam lorazepam medazepam nordazepam oxazepam prazepam

Benzodiazepines possess anti-anxiety properties and can be useful for the short-term treatment of severe anxiety. Like the anticonvulsants, they tend to be mild, well tolerated, and extremely safe. Benzodiazepines are usually administered orally for the treatment of anxiety; however, occasionally lorazepam or diazepam may be given intravenously for the treatment of panic attacks.^[31]

The World Council of Anxiety does not recommend benzodiazepines for the long term treatment of anxiety due to a range of problems associated with long term use of benzodiazepines including tolerance, psychomotor impairment, cognitive and memory impairments, physical dependence and a benzodiazepine withdrawal syndrome upon discontinuation of benzodiazepines.^[32] Despite increasing focus on the use of antidepressants and other agents for the treatment of anxiety, benzodiazepines have remained a mainstay of anxiolytic pharmacotherapy due to their robust efficacy, rapid onset of therapeutic effect, and generally favorable side effect profile.^[33] Treatment patterns for psychotropic drugs appear to have remained stable over the past decade, with benzodiazepines being the most commonly used medication for panic disorder.^[34] Tolerance can develop to the anxiolytic effects of benzodiazepines and their is also a risk of dependence. These factors limit the long term use of benzodiazepines in the treatment of anxiety disorders.^[30]

[edit] Insomnia

Main hypnotic benzodiazepines
brotizolam estazolam flunitrazepam flurazepam flutoprazepam loprazolam lormetazepam midazolam nimetazepam nitrazepam temazepam triazolam

Benzodiazepines are strictly prescribed for the short-term management of severe or debilitating insomnia. Hypnotic benzodiazepines have strong sedative effects, are typically the most rapid-acting benzodiazepines, and have strong receptor affinity. In addition, many of the hypnotics are powerful anticonvulsants (midazolam, nitrazepam, nimetazepam, temazepam, and flutoprazepam) and all are very strong anxiolytics and amnesic agents. Longer-acting benzodiazepines, such as nitrazepam or quazepam, have side-effects that may persist into the next day, whereas the more intermediate-acting benzodiazepines (for example, temazepam or loprazolam) may have less "hangover" effects the next day.^[35] A review of the literature regarding benzodiazepine hypnotic as well as Z drugs concluded that these drugs caused an unjustifiable risk to the individual and to public health. The risks include dependence, accidents and other adverse effects. Gradual discontinuation of hypnotics leads to improved health without worsening of sleep. Preferably they should be prescribed for only a few days at the lowest effective dose and avoided altogether wherever possible in the elderly.^[36] The risks of tolerance and dependence with long term use of benzodiazepines for insomnia limits their use long term.^[30]

[edit] Premedication before procedures

Benzodiazepines can be very beneficial as premedication before surgery, especially in those that are anxious. Usually administered a couple of hours before surgery, benzodiazepines will bring about anxiety relief and also produce amnesia. Amnesia can be useful in this situation, as patients will not be able to remember any unpleasantness from surgery.^[37] Diazepam or temazepam can be utilized in patients who are particularly anxious about dental procedures.^[37] Alternatively nitrous oxide can be administered in dental phobia due to its sedative and dissociative effects, its fast onset of action, and its extremely short duration of action.^[38]

[edit] Intensive care

Benzodiazepines can be very useful in intensive care to sedate patients receiving mechanical ventilation, or those in extreme distress or severe pain. Caution should be exercised in this situation due to the occasional scenario of respiratory depression, and benzodiazepine overdose treatment facilities should be available.^[37]

[edit] Alcohol dependence

Benzodiazepines have been shown to be safe and effective, particularly for preventing or treating seizures and delirium, and are the preferred agents for treating the symptoms of alcohol withdrawal syndrome.^[39] The choice of agent is based on pharmacokinetics. The most commonly used benzodiazepines in the management of alcohol withdrawal are diazepam (Valium) and chlordiazepoxide (Librium), two long-acting agents, and lorazepam (Ativan) and oxazepam (Serax), two intermediate-acting agents. The long half-life of diazepam and chlordiazepoxide make withdrawal smoother, and rebound withdrawal symptoms are less likely to occur. The two intermediate-acting agents have excellent records of efficacy. Chlordiazepoxide is the benzodiazepine of choice in uncomplicated alcohol withdrawal.^[40] Oxazepam is also used in managing alcohol withdrawal. It is often used in patients at risk of drug accumulation, particularly the elderly and those with cirrhosis because of its shorter half life. Lorazepam, also a short acting benzodiazepine is the only benzodiazepine with predictable intramuscular absorption (if intramuscular administration is necessary) and it is the most effective in preventing and controlling acute seizures.^[41] However, the shorter acting benzodiazepines may be less effective than longer acting benzodiazepines eg chlordiazepoxide or diazepam in reducing alcohol withdrawal symptoms eg risk of break through seizures and thus are not recommended for outpatient detoxification. They are more prone to rebound if not tapered after alcohol detoxification.^[42][43]

[edit] Muscular disorders

Benzodiazepines are well known for their strong muscle-relaxing properties, and can be useful in the treatment of muscle spasms, for example, Tetanus or spastic disorders^[44] and restless legs syndrome.

[edit] Acute mania

Mania, a mood disorder, is a state of extreme mood elevation and is a diagnosable serious psychiatric disorder. Benzodiazepines can be very useful in the short-term treatment of acute mania, until the effects of lithium or neuroleptics (antipsychotics) take effect. Benzodiazepines bring about rapid tranquillisation and sedation of the manic individual, therefore benzodiazepines are a very important tool in the management of mania. Both clonazepam and lorazepam are used for the treatment, with some evidence that clonazepam may be superior in the treatment of acute mania.^[45][46]

[edit] Veterinary practice

Benzodiazepines have a wide range of uses in veterinary practice in the treatment of various disorders and scenarios involving animals. As in humans, their usefulness comes from their tranquilizing, muscule relaxing, aggresion inhibiting, and anxiolytic properties.^[47]

Benzodiazepines are used before surgery as premedication for muscular relaxtion,^[48] and during surgery in combination with other general anesthetic drugs such as ketamine.^[49][50] They are effective in controlling tremors, seizures and epilepsy.^[51][52][53]

Midazolam can also be used along with other drugs in the sedation and capture of wild animals.^[54]

[edit] Contraindications, interactions and side effects

[edit] Contraindications

The following are some important contraindications or situations where extreme caution should be exercised when prescribing benzodiazepines.^[55][56][57]

• Myasthenia gravis
• Respiratory disorders
• Severe hepatic insufficiency
• Sleep apnoea syndrome
• Pregnancy, labour and lactation
• Breast feeding
• Chronic pain^[58]
• Phobic or obsessional states
• Chronic psychosis
• Clinical depression and major depressive disorder - risk of worsening depression and thus precipitating suicidal tendencies
• Abrupt or over rapid withdrawal after long term use is contraindicated - risk of a severe benzodiazepine withdrawal syndrome developing with symptoms such as toxic psychosis, convulsions or a condition resembling delirium tremens.
• History of physical dependence on benzodiazepines or other cross tolerant drugs such as other GABAergic sedative hypnotic drugs including alcohol - risk of rapid reinstatement of dependency.^[59] Benzodiazepines increase craving for alcohol in problem alcohol consumers. Benzodiazepines also increase the volume of alcohol consumed by problem drinkers.^[60]
• Driving a motor vehicle, increased risk of road traffic accidents^[61]

[edit] Interactions

Individual benzodiazepines may have their own additional interactions which will vary from benzodiazepine to benzodiazepine.^[62] The interactions of benzodiazepines as a drug class with other drugs are as follows;^[55]

• Alcohol and other CNS depressants - cause synergistic adverse effects, with possible increase in depression and suicide.^[63]
• Antacids and anticholinergics - may slow down absortion which may slow down acute therapeutic effects.
• Oral contraceptives, isoniazid - reduces the rate of elimination and thus the half-life increases leading to possibly excessive drug accumulation.
• Cimetidine Inhibition of metabolism of benzodiazepines, causing accumulation which especially with long half life benzodiazepines such as diazepam may cause toxic effects.
• Rifampicin - increases rate of metabolism, thus shortening the elimination half-life of benzodiazepines
• Digoxin - protein binding of diazepam altered causing increased digoxin levels
• L-dopa - worsening of parkinsonian symptoms
• Disulfiram - slows down the rate of metabolism leading to increased effects of benzodiazepines

[edit] Side-effects

The following list summarizes the side effects which may occur from use of benzodiazepines.^[64]

• Drowsiness
• Dizziness
• Upset stomach
• Blurred vision
• Headache
• Confusion
• Depression
• Euphoria
• Impaired coordination
• Changes in heart rate
• Trembling
• Weakness
• Amnesia
• Hangover effect (grogginess)
• Dreaming or nightmares
• Chest pain
• Vision changes
• Jaundice
• Dissociation or depersonalisation^[65]
• Paradoxical reactions^[66]

[edit] Paradoxical reactions

Severe paradoxical reactions such as physical aggression, criminal acts, impulsivity and violence and suicide can occur but are considered rare occuring in less than 1% of treated patients. However, a meta-analysis has shown that benzodiazepines are more likely to cause aggression than to alleviate it. Individuals with borderline personality disorder are at a greater risk of experiencing severe behavioral or psychiatric disturbances from benzodiazepines with up to 58% of borderline personality disorder patients experiencing behavioural disinhibition.^[67] Aggression and violent outbursts can also occur with benzodiazepines, particularly when they are combined with alcohol. Recreational abusers and patients on high-dosage regimes may be at an even greater risk of experiencing paradoxical reactions to benzodiazepines.^[68] Paradoxical reactions may occur in any individual on commencement of therapy and initial monitoring should take into account the risk of increase in anxiety or suicidal thoughts.^[66] Benzodiazepines can sometimes cause a paradoxical worsening of EEG readings in patients with seizure disorders.^[69]

The core element of a paradoxical rage reaction due to benzodiazepines is a partial deterioration from consciousness, which generates automatic behaviours, anterograde amnesia, and uninhibited aggression, and might occur from disinhibiting a serotonergic mechanism.^[70]

[edit] Physical dependence and withdrawal

Long-term benzodiazepine usage, in general, leads to some form of tolerance and/or drug dependence with the appearance of a benzodiazepine withdrawal syndrome when the benzodiazepines are stopped or the dose is reduced. Withdrawal from chronic benzodiazepine use is usually beneficial due to improved health such as cognition and improved functioning with possible improved employment status. Abrupt withdrawal can be hazardous therefore a gradual withdrawal is recommended. The time needed to complete withdrawal differs from expert to expert but ranges from 4 weeks to several years, with aiming for 6 months suggested by one leading expert.^[5]

Approximately half of patients attending mental health services for conditions including anxiety disorders such as panic disorder or social phobia may be the result of alcohol or benzodiazepine dependence. Sometimes anxiety disorders pre-existed alcohol or benzodiazepine dependence but the alcohol or benzodiazepine dependence often act to keep the anxiety disorders going and often progressively making them worse. Many people who are addicted to alcohol or prescribed benzodiazepines when it is explained to them they have a choice between ongoing ill mental health or quitting and recovering from their symptoms decide on quitting alcohol and or their benzodiazepines. It was noted that every individual has an individual sensitivity level to alcohol or sedative hypnotic drugs and what one person can tolerate without ill health another will suffer very ill health and that even moderate drinking can cause rebound anxiety syndromes and sleep disorders. A person who is suffering the toxic effects of alcohol or benzodiazepines will not benefit from other therapies or medications as they do not address the root cause of the symptoms. Recovery from benzodiazepine dependence tends to take a lot longer than recovery from alcohol but people can regain their previous good health.^[71]

[edit] Withdrawal management

Benzodiazepine withdrawal symptoms occur when benzodiazepine dosage is reduced in people who are physically dependent on benzodiazepines. Abrupt or over-rapid dosage reduction can produce severe withdrawal symptoms. Withdrawal symptoms may also occur during a very gradual and slow dosage reduction but are typically less severe. Withdrawal symptoms may persist as part of a protracted withdrawal syndrome for many months after cessation of benzodiazepines.^[72]

Benzodiazepine withdrawal is best managed by transferring the physically-dependent patient to an equivalent dose of diazepam because it has the longest half-life of all of the benzodiazepines and is available in low-potency, 2-mg tablets, which can be quartered for small dose reductions.^[73] The speed of benzodiazepine reduction regimes varies from person to person, but is usually 10% every two to four weeks. A slow withdrawal, under medical supervision by a physician that is knowledgeable about the benzodiazepine withdrawal syndrome, with the patient in control of dosage reductions coupled with reassurance that withdrawal symptoms are temporary, has been found to produce the highest success rates. The withdrawal syndrome can usually be avoided or minimized by use of a long half-life benzodiazepine such as diazepam (Valium) or chlordiazepoxide (Librium) and a very gradually tapering off the drug over a period of months, or even up to a year or more, depending on the dosage and degree of dependency of the individual. A slower withdrawal rate significantly reduces the symptoms. In fact, some people feel better and more clear-headed as the dose gradually gets lower, so withdrawal from benzodiazepines is not necessarily an unpleasant event. People that report severe experiences from benzodiazepine withdrawal have almost invariably withdrawn or been withdrawn too quickly.^[74]

[edit] Pregnancy

In the United States the FDA has categorised benzodiazepines into either category D or category X benzodiazepines.^[75] International statistics show that 3.5% of women consume psychotropic drugs during pregnancy and of that 3.5% up to 85% report using benzodiazepines during pregnancy making benzodiazepines the most commonly prescribed psychotropic drug consumed during pregnancy. Approximately 0.4% of all pregnancies are to women who have used benzodiazepines chronically throughout their pregnancy.^[76] Use of benzodiazepines during pregnancy may result in a neonatal withdrawal syndrome including irritability, hyperactivity, disturbed sleep pattern, high-pitched crying, tremor, vomiting, diarrhea, weight loss and failure to gain weight.^[77] Benzo babies may have mental retardation, functional deficits, long-lasting behavioural anomalies and lower intelligence as a result of prenatal benzodiazepine exposure.^[78][79] The prenatal toxicity of benzodiazepines is most likely due to their effects on neurotransmitter systems and cell membranes and protein synthesis.^[80] Benzodiazepines, like many other sedative hypnotic drugs causes apoptotic neuronal death. However, benzodiazepines do not cause as severe apoptosis to the developing brain as alcohol does.^[81][82][83]

[edit] Elderly

Benzodiazepines are generally not recommended for the elderly due to a range of adverse effects.^[84] A large cohort study found that benzodiazepine use is associated with a significantly higher incidence of hip fracture. Benzodiazepines of a short half-life are as likely to be associated with hip fracture as long-acting benzodiazepines. Because hip fractures are a frequent cause of disability and death in the elderly, efforts have been underway to reduce benzodiazepine prescribing in the elderly.^[85] A review of the literature from between 1975 and 2005 found that medical papers consistently report increased risk of falls and fractures in the elderly. The review paper also found that benzodiazepine hypnotics produce the most significant effects on body sway. Newer hypnotics (eg zaleplon and zolpidem) do not seem to cause such profound effects as benzodiazepines on the elderly.^[86] Still, a law introduced in New York State reducing benzodiazepine use by 60% did not result in a measurable decrease in hip fractures.^[87] This suggests that any effect of benzodiazepines on fracture rate may be non-significant and more important factors predict fracture rate such as osteoporosis rather than benzodiazepine induced falls.

Benzodiazepines cause an increased morbidity in the elderly which results in an increased use of healthcare services due to the adverse effects of benzodiazepines on the elderly.^[88] The elderly are more sensitive to benzodiazepines and are at an increased risk of dependence. Up to 10% of hospital admissions of the elderly are because of benzodiazepines. The elderly are more sensitive to the intellectual and cognitive impairing effects of benzodiazepines including amnesia, diminished short-term recall, and increased forgetfulness. Chronic use of benzodiazepines and benzodiazepine dependence in the elderly can resemble dementia, depression or anxiety syndromes, which worsens with longer-term use of benzodiazepines. The success of gradual-tapering benzodiazepines is as great in the elderly as in younger people. Benzodiazepines should be prescribed to the elderly only with caution and only for a short period at low doses.^[89]

An extensive review of the medical literature regarding the management of insomnia and the elderly found that there is significant evidence of the effectiveness and long term effectiveness of non-drug treatments for insomnia in adults, including the elderly and found that these interventions are underused. Nonbenzodiazepine sedative-hypnotics compared with benzodiazepines appeared to offer few, if any, significant clinical advantages in efficacy or tolerability in elderly persons. Melatonin agonists, such as ramelton are more suitable for the management of chronic insomnia in elderly people. The review stated that long-term use of sedative-hypnotics for insomnia lacks an evidence base and has traditionally been discouraged for reasons that include concerns about such potential adverse drug effects as cognitive impairment (anterograde amnesia), daytime sedation, motor incoordination, and increased risk of motor vehicle accidents and falls. In addition, the effectiveness is unproven and the safety of long-term use of these agents is unknown. It was concluded that more research is needed to evaluate the long-term effects of treatment and the most appropriate management strategy for elderly persons with chronic insomnia.^[90]

[edit] Overdose

See main article: Benzodiazepine overdose

Benzodiazepines taken alone rarely cause severe complications in overdose,^[91] and deaths after hospital admission are rare.^[92] However, combination of these drugs with alcohol or opiates is particularly dangerous, and may lead to coma and death.^[93][94] The various benzodiazepines differ in their toxicity since they produce varying levels of sedation in overdose, with oxazepam being least toxic and least sedative and temazepam most toxic and most sedative in overdose. Temazepam is more frequently involved in drug-related deaths causing more deaths per million than other benzodiazepines in an Australian study.^[95]

A reversal agent for benzodiazepines exists, flumazenil (Anexate). Its use as an antidote in an overdose however is controversial. Numerous contraindications to its use exist. It is contraindicated in patients who are on long term benzodiazepines, those who have ingested a substance that lowers the seizure threshold or may cause an arrhythmia, and in those with abnormal vital signs. One study found that this is about 10% of the patient population presenting with a benzodiazepine overdose.^[96]

[edit] Benzodiazepine drug misuse

[edit] Drug misuse

Benzodiazepines are used/abused recreationally and activate the dopaminergic reward pathways in the central nervous system.^[97][98]

Benzodiazepine use is widespread among amphetamine abusers, those that use amphetamines and benzodiazepines have greater levels of mental health problems and social deterioration. Benzodiazepine injectors are almost four times more likely to inject using a shared needle than non-benzodiazepine-using injectors. It has been concluded in various studies that benzodiazepine use causes greater levels of risk and psycho-social dysfunction among drug abusers.^[99] Those who use stimulant and depressant drugs are more likely to report adverse reactions from stimulant use, more likely to be injecting stimulants, and more likely to have been treated for a drug problem than those using stimulant but not depressant drugs.^[100] Increased mortality was found in drug misusers that also used benzodiazepines against those that did not. Heavy alcohol misuse was also found to increase mortality among multiple-drug misusers.^[101]

Drug misusers addicted to benzodiazepines develop a high degree of tolerance, coupled with dosage escalation, often increasing their dosage to very high levels. Long-term use of benzodiazepines has the potential to cause both physical and psychological dependence, and are at risk of severe withdrawal symptoms. Tolerance and dependence to benzodiazepines develop rapidly with users of benzodiazepines, demonstrating benzodiazepine withdrawal syndrome after as little as 3 weeks of continuous use. Benzodiazepines, and in particular temazepam, are sometimes used intravenously, which if done incorrectly, or in an unsterile manner, or by using shared syringes & needles can lead to medical complications including abscesses, cellulitis, thrombophlebitis, arterial puncture, deep vein thrombosis, hepatitis B and C, HIV or AIDS, overdose and gangrene. Benzodiazepines are also sometimes abused intranasally which may have additional health consequences. Once benzodiazepine dependence has been established a clinician usually convert the patient to an equivalent dose of diazepam before beginning a gradual reduction program. Additional drugs, such as antianxiety drugs like buspirone or β blockers, and carbamazepine, should not be added into the withdrawal program unless there is a specific indication for their use.^[102]

[edit] Drug related crime

Problem benzodiazepine use can be associated with drug related crime. In a survey of police detainees carried out by the Australian Government, both legal and illegal users of benzodiazepines were found to be more likely to have lived on the streets, less likely to have been in full time work, and more likely to have used heroin or methamphetamines in the past 30 days from the date of taking part in the survey. Benzodiazepine users were also more likely to be receiving illegal incomes and more likely to have been arrested or imprisoned in the previous year. Benzodiazepines were sometimes reported to be abused alone, but most often formed part of a poly drug-using problem. Female users of benzodiazepines were more likely than men to be using heroin, whereas male users of benzodiazepines were more likely to report amphetamine use. Benzodiazepine users were more likely than non-users to claim government financial benefits, and benzodiazepine users who were also poly-drug users were the most likely to be claiming government financial benefits. Those who reported using benzodiazepines alone were found to be in the mid range when compared to other drug using patterns in terms of property crimes and criminal breaches. Of the detainees reporting benzodiazepine use, one in five reported injection use, mostly of illicit temazepam, but some reported injecting prescribed benzodiazepines. Injection was a concern in this survey due to increased health risks. The main problems highlighted in this survey were concerns of dependence, the potential for overdose of benzodiazepines in combination with opiates and the health problems associated with injection of benzodiazepines.^[103] Benzodiazepines are also sometimes used for criminal purposes such as to rob a victim or to incapacitate a victim in cases of drug assisted rape.^[104]

[edit] Drug regulation and enforcement

[edit] Europe

In 2006/2007, seizures of benzodiazepines had trebled from the previous 2 years in the United Kingdom. Temazepam abuse and seizures have been falling in the UK probably due to its reclassification as Schedule III controlled drug with tighter prescribing restrictions and the resultant reduction in availability of temazepam.^[105] A total of 2.75 million temazepam capsules were seized in the Netherlands by authorities between 1996 and 1999.^[106]

[edit] Oceania

Benzodiazepines are common drugs of abuse in Australia and New Zealand, particularly among those who may also be using other illicit drugs. The intravenous use of temazepam poses the greatest threat to those who misuse benzodiazepines. Simultaneous consumption of temazepam with heroin is a potential risk factor of overdose. An Australian study of non-fatal heroin overdoses, noted that 26% of heroin users had consumed temazepam at the time of their overdose. This is consistent with a NSW investigation of coronial files from 1992. Temazepam was found in 26% of heroin-related deaths. Temazepam, including tablet formulations, are used intravenously. In an Australian study of 210 heroin users who used temazepam, 48% had injected it. Although abuse of benzodiazepines has decreased over the past few years, temazepam continues to be a major drug of abuse in Australia. In certain states like Victoria and Queensland, temazepam accounts for most benzodiazepine sought by forgery of prescriptions and through pharmacy burglary. Darke, Ross & Hall found that different benzodiazepines have different abuse potential. The more rapid the increase in the plasma level following ingestion, the greater the intoxicating effect and the more open to abuse the drug becomes. The speed of onset of action of a particular benzodiazepine correlates well with the ‘popularity’ of that drug for abuse. Darke, Ross & Hall found that temazepam rated significantly higher than the next most liked drug, nimetazepam. The two most common reasons for this preference were that it was the ‘strongest’ and that it gave a good ‘high’.^[107]

[edit] North America

Abuse of benzodiazepine drugs is a serious problem in North America. The most frequently abused of the benzodiazepines in both the United States and Canada are alprazolam, clonazepam, lorazepam, and diazepam. The powerful hypnotic agents temazepam and triazolam are also subject to misuse, though they are not as readily available as the aforementioned four. Temazepam and triazolam have seen a steep decline in prescription rates, because of the emergence of newer and safer hypnotics like zaleplon and zolpidem.^{[108][109][110]}

[edit] East and Southeast Asia

Abuse of benzodiazepines is a serious problem throughout East and Southeast Asia. The Central Narcotics Bureau of Singapore seized 94,200 nimetazepam tablets in 2003. This is the largest nimetazepam seizure recorded since nimetazepam became a controlled drug under the Misuse of Drugs Act in 1992.^[111] Together with temazepam abusers, they accounted for 47% of the abusers arrested in 2005.^[112] In Singapore, both temazepam and nimetazepam are Class A Schedule I controlled drugs. Similar harsh laws apply to both of these benzodiazepines all across Asia. In Hong Kong, for example, they're both regulated under Schedule 1 of Hong Kong's Chapter 134 Dangerous Drugs Ordinance.

[edit] Legal status

Benzodiazepines are Schedule IV in the USA under the Federal Controlled Substances Act, even when not on the market (for example, nitrazepam and bromazepam). Flunitrazepam is subject to more stringent regulations in certain states, and temazepam prescriptions require specially coded pads in certain states. In Canada all benzodiazepines are Schedule IV.^[113]

Elsewhere in the world, however, benzodiazepines, which are often subject to heavy abuse and addiction, are often more strictly regulated or controlled. Temazepam, nimetazepam and flunitrazepam are the world's most heavily regulated benzodiazepines.

Throughout Europe, including the United Kingdom, temazepam and flunitrazepam also carry tougher penalties for trafficking and possession.^[114]

In the Netherlands, since October 1993, benzodiazepines are all placed on List 2 of the Opium Law, with the exception of any 20mg temazepam formulations, which are List 1. A prescription is needed for possession of all benzodiazepines.

In East Asia and Southeast Asia, temazepam and nimetazepam are often heavily controlled and restricted. In certain countries, triazolam, flunitrazepam, flutoprazepam, and midazolam are also restricted or controlled to certain degrees. In Hong Kong all benzodiazepines were reclassified as dangerous drugs and are regulated under Schedule 1 of Hong Kong's Chapter 134 Dangerous Drugs Ordinance. Previously only brotizolam, flunitrazepam, and triazolam were classed as dangerous drugs.^[115]

Internationally, temazepam, nimetazepam, and flunitrazepam are Schedule III drugs under the Convention on Psychotropic Substances.^[116] As such, penalties for their possession and/or trafficking are more severe than all other benzodiazepine drugs, which are classified as Schedule IV.

Various other countries limit the availability of benzodiazepines legally. Even though it is a commonly prescribed class of drugs, the Medicare Prescription Drug, Improvement, and Modernization Act specifically states that insurance companies that provide Medicare Part D plans are not allowed to cover benzodiazepines in Plan D.

[edit] See also

• Benzodiazepine withdrawal syndrome
• Long term effects of benzodiazepines
• Benzodiazepine dependence
• Benzodiazepine equivalence
• Nonbenzodiazepine
• Barbiturate
• Z drugs

[edit] References

[edit] External links

• Ashton CH (2002-08-01). "Benzodiazepines How They Work & How to Withdraw". benzo.org.uk. http://www.benzo.org.uk/manual/. Retrieved on 2008-06-19. 
• Ashton CH (2007-04-01). "Benzodiazepine Equivalence Table". benzo.org.uk. http://www.benzo.org.uk/bzequiv.htm. Retrieved on 2008-06-19. 
• Fruchtengarten L, (1998-04-01). "Benzodiazepines". PIM G008. International Programme on Chemical Safety (IPCS) INCHEM. http://www.inchem.org/documents/pims/pharm/pimg008.htm. Retrieved on 2008-06-19. 
• Longo LP, Johnson B (2000-04-01). "Benzodiazepines Side Effects, Abuse Risk and Alternatives". Addiction: Part I. American Academy of Family Physicians. http://www.aafp.org/afp/20000401/2121.html. Retrieved on 2008-06-19. 
• "An Overview of the History, Chemistry, and Pharmacodynamics of Benzodiazepines". The Eaton T. Fores Research Center. 2002-01-01. http://www.etfrc.com/benzos1.htm. Retrieved on 2008-06-19. 
• "Benzodiazepines advanced consumer information". drugs.com. 2005-02-24. http://www.drugs.com/cons/benzodiazepines.html. Retrieved on 2008-06-19. 

v • d • e GABA agonists and antagonists GABA agonists GABAA receptor: Barbiturates · Benzodiazepines · Nonbenzodiazepines (Zolpidem, Zopiclone, Zaleplon) · Gaboxadol · Muscimol GABAB receptor: Baclofen · Phenibut · GHB GABAC receptor: CACA · CAMP · N(4)-chloroacetylcytosine arabinoside other/nonspecific/unsorted: GABA · Picamilon · Methaqualone · Progabide · Ethanol GABA antagonists GABAA receptor: Bicuculline · Flumazenil · Picrotoxin · Cicutoxin · Oenanthotoxin GABAB receptor: Saclofen · Phaclofen · SCH-50911 GABAC receptor: TPMPA other/nonspecific/unsorted: Pentylenetetrazol Indirect GABA agents Glutamate decarboxylase inhibitors (anabolism) Allylglycine GABA transaminase inhibitors (catabolism) Gabaculine · Valproic acid · Vigabatrin GABA reuptake inhibitors CI-966 · Deramciclane · Guvacine · Nipecotic acid · NNC 05-2090 · SKF-89976A · SNAP-5114 · Tiagabine

v • d • e Benzodiazepines (N05BA, N05CD) 1,4-Benzodiazepines Bromazepam • Camazepam • Chlordiazepoxide • Cinolazepam • Clonazepam • Clorazepate • Cyprazepam • Delorazepam • Diazepam • Doxefazepam • Elfazepam • Ethyl carfluzepate • Ethyl dirazepate • Ethyl loflazepate • Fletazepam • Fludiazepam • Flunitrazepam • Flurazepam • Flutemazepam • Flutoprazepam • Fosazepam • Gidazepam • Halazepam • Iclazepam • Lopirazepam • Lorazepam • Lormetazepam • Meclonazepam • Medazepam • Menitrazepam • Metaclazepam • Nimetazepam • Nitrazepam • Nitrazepate • Nordazepam • Oxazepam • Phenazepam • Pinazepam • Pivoxazepam • Prazepam • Proflazepam • Quazepam • QH-II-66 • Reclazepam • Sulazepam • Temazepam • Tetrazepam • Uldazepam 1,5-Benzodiazepines Arfendazam • Clobazam • Lofendazam • Triflubazam • Zomebazam 2,3-Benzodiazepines Girisopam • GYKI-52466 • GYKI-52895 • Nerisopam • Tofisopam Triazolobenzodiazepines Adinazolam • Alprazolam • Estazolam • Triazolam  Imidazobenzodiazepines Bretazenil • Climazolam • Flumazenil • Imidazenil • L-655,708 • Loprazolam • Midazolam • PWZ-029 • Ro15-4513 • Ro48-6791 • Sarmazenil • SH-053-R-CH3-2′F Oxazolobenzodiazepines Cloxazolam • Flutazolam • Haloxazolam • Mexazolam • Oxazolam Thienodiazepines Brotizolam • Ciclotizolam • Clotiazepam • Etizolam Pyridodiazepines Zapizolam • Lopirazepam Pyrazolodiazepines Ripazepam • Zolazepam Pyrrolodiazepines Premazepam Benzodiazepine Prodrugs Avizafone • Rilmazafone Others Bentazepam • Devazepide • Ketazolam • Razobazam • Tifluadom

v • d • e Anticonvulsants (N03) GABAA receptor agonist Barbiturates Barbexaclone · Metharbital · Methylphenobarbital · Pentobarbital · Phenobarbital · Primidone Benzodiazepines Clobazam · Clonazepam · Clorazepate · Diazepam · Flutoprazepam · Lorazepam · Midazolam · Nimetazepam · Nitrazepam · Temazepam Other GABA agents Aromatic allylic alcohols Stiripentol Carbonic anhydrase inhibitor Sulfa drugs Acetazolamide · Ethoxzolamide · Sultiame · Zonisamide Sodium channel blocker/ Calcium channel blocker Hydantoins Ethotoin · Fosphenytoin · Mephenytoin · Phenytoin Succinimides Ethosuximide · Mesuximide · Phensuximide Carboxamides Carbamazepine · Oxcarbazepine · Rufinamide Phenyltriazines Lamotrigine GABA analogs Gabapentin · Pregabalin · Progabide · Vigabatrin Oxazolidinediones Ethadione · Paramethadione · Trimethadione Ureas Phenacemide · Pheneturide GABA agents and channel blockers Fatty acid derivatives Valpromide · Valnoctamide Carboxylic acids Valproic acid (Sodium valproate & Valproate semisodium) · Tiagabine Unknown/multiple/ unsorted Monosaccharides Topiramate Carbamates Emylcamate · Felbamate · Meprobamate · Carisbamate Pyrrolidines Brivaracetam · Levetiracetam · Nefiracetam · Seletracetam Propionates Beclamide · Lacosamide Aldehydes Paraldehyde Bromides Potassium bromide · Sodium bromide

v • d • e Psycholeptics: anxiolytics (tranquilisers) (N05B) GABAA receptor Benzodiazepine Adinazolam • Alprazolam • Bretazenil • Bromazepam • Camazepam • Chlordiazepoxide • Clobazam • Clorazepate • Clonazepam • Clotiazepam • Cloxazolam • Diazepam • Ethyl loflazepate • Etizolam • Fludiazepam • Halazepam • Imidazenil • Ketazolam • Lorazepam • Medazepam • Nordazepam • Oxazepam • Pinazepam • Prazepam • Tofisopam Nonbenzodiazepine Adipiplon • Alpidem • CGS-9896 • CGS-20625 • DOV-51892 • ELB-139 • Etifoxine • L-838,417 • MK-0343 • NS-2664 • NS-2710 • Ocinaplon • Pagoclone • Panadiplon • Pipequaline • RWJ-51204 • SB-205,384 • TP-003 • TP-13 • TPA-023 • Tracazolate • Y-23684 β-Carbolines Abecarnil • Gedocarnil • SL-651,498 Carbamates Emylcamate • Carisoprodol • Mebutamate • Meprobamate • Phenprobamate • Tybamate Serotonin 5-HT1A agonist Azaspirodecanedione Binospirone • Buspirone • Gepirone • Ipsapirone • Tandospirone • Tiospirone Other 8-OH-DPAT • Flesinoxan Histamine H1 antagonist Diphenylmethane Captodiame • Hydroxyzine CRF antagonists CRF-1 antagonists Antalarmin • CP-154,526 • Pexacerfont Other/ungrouped Other Benzoctamine • Chlormezanone • Eglumegad • Etazolate • Fenobam • Fominoben • Mebicar • Mephenoxalone • Saredutant • Synaptamine • Trimetozine

v • d • e Psycholeptics: hypnotics and sedatives (N05C) GABAA receptor Barbiturates Allobarbital • Amobarbital • Aprobarbital • Barbital • Butobarbital • Cyclobarbital • Ethallobarbital • Heptabarbital • Hexobarbital • Methohexital • Pentobarbital • Phenobarbital • Proxibarbal • Reposal • Secobarbital • Talbutal • Thiopental • Vinylbital • Vinbarbital Benzodiazepines Brotizolam • Cinolazepam • Doxefazepam • Estazolam • Flunitrazepam • Flurazepam • Flutoprazepam • Loprazolam • Lormetazepam • Nitrazepam • Nimetazepam • Midazolam • Quazepam • Temazepam • Triazolam Nonbenzodiazepines CL-218,872 • Eszopiclone • Indiplon • Necopidem • Pazinaclone • ROD-188 • Saripidem • Suproclone • Suriclone • SX-3228 • U-89843A • U-90042 • Zaleplon • Zolpidem • Zopiclone Piperidinediones Glutethimide • Methyprylon • Pyrithyldione • Piperidione Quinazolinones Afloqualone • Cloroqualone • Diproqualone • Etaqualone • Mebroqualone • Mecloqualone • Methaqualone • Methylmethaqualone Neuroactive steroids Acebrochol • Allopregnanolone • Alphadolone • Alphaxolone • Ganaxolone • Hydroxydione • Minaxolone • Org 20599 • Tetrahydrodeoxycorticosterone Alpha-2 adrenergic receptor Alpha-adrenergic agonists 4-NEMD • Clonidine • Dexmedetomidine • Lofexidine • Medetomidine • Romifidine • Tizanidine • Xylazine Melatonin receptor Melatonin Agomelatine • Melatonin • Ramelteon • Tasimelteon Histamine receptor & Acetylcholine receptor Antihistamines & Anticholinergics Doxylamine • Hydroxyzine • Diphenhydramine • Bromodiphenhydramine • Carbinoxamine • Orphenadrine • Niaprazine • Phenyltoloxamine • Propiomazine • Pyrilamine • Scopolamine GABAB receptor / GHB receptor GHB Type 1,4-Butanediol • Aceburic acid • GABOB • GHB (Sodium Oxybate, Xyrem®) • GBL • gamma-Valerolactone • N-Methyl-GABA Orexin receptors Orexin antagonists Almorexant • SB-334,867 • SB-408,124 • SB-649,868 • TCS-OX2-29 Other receptors/ ungrouped Aldehydes Acetylglycinamide chloral hydrate • Chloral hydrate • Chloralodol • Dichloralphenazone • Paraldehyde • Petrichloral Alkynes Centalun • Ethchlorvynol • Ethinamate • Hexapropymate • Methylpentynol Carbamates Meprobamate • Carisoprodol • Tybamate • Methocarbamol Other 2-Methyl-2-butanol • Acecarbromal • Apronal • Bromides • Bromisoval • Carbromal • Chloralose • Clomethiazole • Embutramide • Etomidate • Evoxine • Gaboxadol • Loreclezole • Mephenoxalone • Sulfonmethane • Trichloroethanol • Triclofos • Valerian • Valnoctamide • Trazodone